SCHEDULE: FMR LLC Amends Silicon Labs Stake to 2.1%

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a 2.1% beneficial ownership stake in Silicon Laboratories Inc. as of February 27, 2026.

Summary

• FMR LLC and Abigail P. Johnson filed an Amendment No. 16 to Schedule 13G for Silicon Laboratories Inc.
• The filing reports beneficial ownership of 697,454.83 shares of common stock, representing 2.1% of the class.
• The event requiring this filing occurred on February 27, 2026.
• FMR LLC holds sole voting power over 695,746.00 shares and sole dispositive power over 697,454.83 shares.
• Abigail P. Johnson, as an individual, holds sole dispositive power over 697,454.83 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• FMR LLC is classified as a parent holding company or control person, and Abigail P. Johnson is classified as an individual.
• Several FMR LLC subsidiaries, including Fidelity Diversifying Solutions LLC, Fidelity Management & Research Company LLC, Fidelity Management Trust Company, and Strategic Advisers LLC, are identified as relevant entities.
• Abigail P. Johnson, as Director, Chairman, and CEO of FMR LLC, along with other Johnson family members, are predominant owners of FMR LLC's Series B voting common shares, potentially forming a controlling group.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral filing, primarily a routine disclosure of beneficial ownership by a large institutional investor. It reflects a continued, non-controlling stake in Silicon Laboratories Inc. without indicating any significant positive or negative operational developments for the issuer.

Risks

• The Johnson family group, through their ownership of voting common shares and a shareholders' voting agreement, may be deemed to form a controlling group with respect to FMR LLC, which could influence FMR LLC's decisions regarding its investment in Silicon Laboratories Inc.

Future Outlook

NA

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.

Industry Context

StockSavvy.ai notes that FMR LLC, a major institutional investor, maintaining a 2.1% stake in Silicon Laboratories Inc. indicates continued confidence in the semiconductor and IoT solutions sector. This level of ownership is typical for large asset managers who hold diversified portfolios and are not seeking active control, aligning with standard passive investment strategies in the technology industry.

Comparison to Industry Standards

• FMR LLC's 2.1% stake in Silicon Laboratories Inc. is a relatively small, passive position for a large institutional investor, consistent with diversified portfolio management rather than activist investing.
• Compared to activist funds that often target stakes above 5% to influence corporate strategy, FMR LLC's current holding suggests a long-term, non-interventional investment approach, similar to Vanguard or BlackRock's typical passive index or actively managed fund holdings in publicly traded companies.

Corporate Governance

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, confirming a passive investment approach.
• Management: No direct impact on Silicon Laboratories Inc. management, as FMR LLC is not seeking control.

Key Dates

Recommendation

This Schedule 13G filing is a routine disclosure of beneficial ownership by a large institutional investor, FMR LLC, maintaining a 2.1% stake in Silicon Laboratories Inc. The filing explicitly states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. As such, it provides no new material information regarding the operational performance, strategic direction, or financial health of Silicon Laboratories Inc. that would warrant a change in investment thesis. The current holding reflects a passive investment, suggesting no immediate catalyst for significant price movement based solely on this filing. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current position while awaiting more substantive company-specific news or financial reports.

Keywords

FMR LLC, Abigail P. Johnson, Silicon Laboratories Inc., SLAB, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Investment Management